SCHEMBL26201631

SCHEMBL26201631

COCC[C@@H]1[C@@H](C)OC(n2c[n+](C)c3c(=O)[nH]c(N)nc32)[C@@H]1O

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 5/20 0.38
HINT1 P49773 3/20 0.36
NT5E P21589 1/20 0.36
STING1 Q86WV6 1/20 0.36
GSK3A P49840 2/20 0.34
RPS6KA3 P51812 2/20 0.34
MAPK14 Q16539 2/20 0.34
TGM2 P21980 1/20 0.34
FUT5 Q11128 1/20 0.34
PNP P00491 1/20 0.33
EIF4E P06730 1/20 0.33
KRAS P01116 2/20 0.33
DCPS Q96C86 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26202558 1.00 TLR7 (0.38) TLR7HINT1NT5ESTING1GSK3A
SCHEMBL26201989 0.95 TLR7 (0.36) TLR7HINT1NT5ESTING1GSK3A
SCHEMBL26201881 0.91 HINT1 (0.37) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26202070 0.91 HINT1 (0.39) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26571022 0.91 HINT1 (0.39) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26566855 0.91 HINT1 (0.39) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26201971 0.90 TLR7 (0.38) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26569369 0.90 HINT1 (0.37) TLR7HINT1NT5EGSK3ARPS6KA3
SCHEMBL26213741 0.90 HINT1 (0.37) TLR7HINT1NT5ESTING1GSK3A
SCHEMBL26569031 0.90 TLR7 (0.37) TLR7HINT1NT5ESTING1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4261217-A1 COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND Guangzhou Henovcom Bioscience Co., Ltd. (CN) 2023-10-18 EP disclosed
WO-2023159930-A1 COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND 广州市恒诺康医药科技有限公司 2023-08-31 WO disclosed